450. Evaluation of Linezolid Pharmacokinetics in Obese Patients with Severe Skin and Soft-Tissue Infections

BACKGROUND: Linezolid is an oxazolidinone antibiotic with broad activity against Gram-positive bacteria and serves as an option for treating severe skin and soft-tissue infections (SSTIs). Adult FDA-labeled dosing is fixed at 600 mg IV/PO twice daily. Although conflicting, current literature is sugg...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackman, Alison L, Jarugula, Praneeth, Nicolau, David P, Ho Chui, Sai, Joshi, Manjari, Gopalakrishnan, Mathangi, Heil, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809085/
http://dx.doi.org/10.1093/ofid/ofz360.523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809085/
http://dx.doi.org/10.1093/ofid/ofz360.523

Ejemplares similares